Pfizer Agrees to Pay Nearly 60M to Resolve False Claims Allegations Relating to Improper Physician Payments by Subsidiary - FedKite: AI-Driven Solutions and Resources for Federal Inmates & Families

This topic is empty.

Viewing 0 reply threads

Author

Posts
- January 25, 2025 at 3:14 am #5511
  
  Kris Marker
  Keymaster
  
  Pharmaceutical company Pfizer Inc. (Pfizer), on behalf of its wholly-owned subsidiary Biohaven Pharmaceutical Holding Company Ltd. (Biohaven), has agreed to pay $59,746,277 to resolve allegations that, prior to Pfizer’s acquisition of the company, Biohaven knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to health care providers to induce prescriptions of Biohaven’s drug Nurtec ODT.
Author

Posts

Viewing 0 reply threads

You must be logged in to reply to this topic.